These studies demonstrate the application of proteomics in elucidating insulin signaling pathways and highlight its significance in uncovering the mechanisms of T2DM, providing deeper insights into the complex network of insulin signaling for advancing T2DM research and treatment. This evidence concerns the gene INS and type 2 diabetes mellitus.